Transaction · 0001062993-25-002744

ROBINS CHAD M

ROBINS CHAD M, CHAIR, reported a transaction classified as exercise at Adaptive Biotechnologies Corp involving 158921.000000 shares for an estimated $0.00. Reported holdings after the transaction were 496347.000000 shares. The stored filing text includes a detected 10b5-1 reference.

exerciseSEC transaction code MCHAIR
ADPTAdaptive Biotechnologies Corp
Filing timeFeb 19
Trade dateFeb 14, 2025
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
…
Pre-filing
…
Returns since
…

ADPT price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
ADPT since 2025-02-19Filed 563 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Derivative
Type
exercise
Code M
Identifier
0001062993-25-002744
Stock Option (right to buy)
Transaction date
Feb 14, 2025
Filed Feb 19, 2025, 01:21 AM · 5d delay
Shares
158k sh
$0 per share
Estimated value
$0
Computed from shares × price
Holdings after
496k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Derivative Transaction Direct Ownership Large Holdings Reduction 10b5-1 Detected
-20score
Filing-only score

-20

Compact filing score computed from stored Form 4 facts. Version v1.

Low filing signal

This filing has a meaningfully negative filing-only score. It is likely less useful as a positive insider-activity signal.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

CEO and Chairman

Officer YesDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 26, 2024. The option expires on June 9, 2025.

  2. F2

    The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $8.30 to 8.56, inclusive. The reporting person undertakes to provide to…

  3. F3

    The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $8.30 to 8.69, inclusive. The reporting person undertakes to provide to…

  4. F4

    The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $8.30 to 8.91, inclusive. The reporting person undertakes to provide to…

  5. F5

    The option is fully vested and exercisable.

Original filing · 0001062993-25-002744
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

ADPT